US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

290.35

+11.194.01%

Pre-market: 300.9010.55+3.63%04:36 EDT

Volume:804.93K

Turnover:234.29M

Market Cap:34.39B

PE:-78.40

High:298.00

Open:297.00

Low:287.33

Close:279.16

Loading ...

Overview Company News Filings

Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication

MT Newswires Live

Stock Track | BeiGene Plummets 5.60% in Pre-market as Trump's Drug Pricing Plan Rattles Pharma Stocks

Stock Track | BeiGene Plunges 6.86% as Trump's Drug Price Plan Rattles Asia Pharma Stocks

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

BeiGene Is Maintained at Buy by Guggenheim

BeiGene price target raised to $350 from $348 at Guggenheim

RBC Trims Price Target on BeiGene to $311 From $312, Keeps Outperform Rating

MT Newswires Live

Beigene Ltd reports results for the quarter ended March 31 - Earnings Summary

Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat

Stock Track | BeiGene Plunges 5.25% Pre-Market Despite Strong Q1 Results and Maintained 2025 Guidance

BeiGene Swings to Q1 Adjusted Earnings, Revenue Increases; 2025 Revenue Outlook Reiterated

MT Newswires Live

BeiGene sees FY25 revenue $4.9B-$5.3B, consensus $5.09B

CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate

Beigene Ltd expected to post a loss of 74 cents a share - Earnings Preview

3 Stocks That Could Be Trading Below Their Estimated Fair Value

Simply Wall St.

BeiGene Price Target Maintained With a $312.00/Share by RBC Capital

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

BeiGene Is Maintained at Overweight by JP Morgan

BeiGene to Announce First Quarter 2025 Financial Results on May 7

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ONC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":290.35,"timestamp":1752782400000,"preClose":279.16,"halted":0,"volume":804925,"hourTrading":{"tag":"盘前","latestPrice":300.9,"preClose":290.35,"latestTime":"04:36 EDT","volume":370,"amount":111352.29550000001,"timestamp":1752827812036},"delay":0,"floatShares":75541600,"shares":118450658,"eps":-3.70325,"marketStatus":"Pre-Mkt","change":11.19,"latestTime":"07-18 05:15:58 EDT","open":297,"high":298,"low":287.33,"amount":234286477.13349998,"amplitude":0.038222,"askPrice":300.9,"askSize":20,"bidPrice":300.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.70325,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752845400000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":290.35,"preHourTrading":{"tag":"盘前","latestPrice":300.9,"preClose":290.35,"latestTime":"04:36 EDT","volume":370,"amount":111352.29550000001,"timestamp":1752827812036},"postHourTrading":{"tag":"盘后","latestPrice":290.35,"preClose":290.35,"latestTime":"18:58 EDT","volume":2517,"amount":730606.265,"timestamp":1752793098926},"volumeRatio":2.1777109353493556,"impliedVol":0.4681,"impliedVolPercentile":0.791},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75541600,"roa":"-3.22%","roe":"-11.44%","lyrEps":-6.124009,"volumeRatio":2.1777109353493556,"shares":118450658,"dividePrice":0,"high":298,"amplitude":0.038222,"preClose":279.16,"low":287.33,"week52Low":148.81,"pbRate":"9.83","psRate":"8.24","week52High":298,"institutionHeld":0,"latestPrice":290.35,"committee":0.666667,"eps":-3.70325,"divideRate":0,"volume":804925,"delay":0,"ttmEps":-3.70325,"open":297,"prevYearClose":184.71,"prevWeekClose":250.3,"prevMonthClose":242.07,"prevQuarterClose":242.07,"fiveDayClose":253.39,"twentyDayClose":254.09,"sixtyDayClose":229.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537371571","title":"Beigene's Cancer Drug Tevimbra Recommended by EU Panel for Extension of Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2537371571","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537371571?lang=en_us&edition=fundamental","pubTime":"2025-05-23 22:13","pubTimestamp":1748009639,"startTime":"0","endTime":"0","summary":"The European Medicines Agency's Committee for Medicinal Products for Human Use said Friday it recommended an extension of therapeutic indication for Beigene's  cancer drug Tevimbra.Tevimbra is already authorized in the EU, the committee said, with indications for non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, and oesophageal squamous cell carcinoma.Price: 240.05, Change: +1.29, Percent Change: +0.54","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","06160","BK4526","ONC","BK4156"],"gpt_icon":0},{"id":"1162268752","title":"Stock Track | BeiGene Plummets 5.60% in Pre-market as Trump's Drug Pricing Plan Rattles Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1162268752","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162268752?lang=en_us&edition=fundamental","pubTime":"2025-05-12 20:04","pubTimestamp":1747051447,"startTime":"0","endTime":"0","summary":"BeiGene Ltd.  shares plunged 5.60% in pre-market trading on Monday, following President Trump's announcement of an executive order aimed at lowering prescription drug costs in the United States. The move has sent shockwaves through the Asian pharmaceutical sector, with BeiGene among the hardest hit.The sharp decline comes after President Trump declared his intention to sign an executive order implementing a \"Most Favored Nation\" policy. This policy would tie U.S. government drug prices to those ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c16d71d2eba9cb3da9792d48223abc57","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"1190598443","title":"Stock Track | BeiGene Plunges 6.86% as Trump's Drug Price Plan Rattles Asia Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1190598443","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190598443?lang=en_us&edition=fundamental","pubTime":"2025-05-12 10:04","pubTimestamp":1747015462,"startTime":"0","endTime":"0","summary":"BeiGene Ltd.  experienced a significant 24-hour plunge of 6.86% in the night session, as President Trump's announcement to lower prescription drug costs sent shockwaves through the Asian pharmaceutical sector.The decline comes in response to President Trump's declaration that he would sign an executive order implementing a \"Most Favored Nation\" policy. This policy aims to tie U.S. government drug prices to those paid by other countries, potentially affecting the profitability of pharmaceutical c","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"613df4b61bc3692be0fcc4204cdfad36","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | BeiGene Plunges 6.86% as Trump's Drug Price Plan Rattles Asia Pharma Stocks","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"2534686492","title":"Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2534686492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534686492?lang=en_us&edition=fundamental","pubTime":"2025-05-12 10:01","pubTimestamp":1747015260,"startTime":"0","endTime":"0","summary":"Shares of Asia drugmakers fell on Monday after President Trump said he would sign an executive order aimed at lowering the cost of prescription drugs.Among Japanese drugmakers, many of which generate significant parts of their revenue in the U.S., share of Daiichi Sankyo were recently down 5.5%. Otsuka Holdings was 3.7% lower and Roche Holding's Japanese unit, Chugai Pharmaceutical, was down 6.0%.Revenue from the U.S. made up about a third of Daiichi Sankyo's total revenue for the fiscal year ended March. At Otsuka's pharmaceutical business, North America accounted for about a half of revenue in 2024.In Seoul, Daewoong Pharmaceutical was trading 4.6% lower, while Samsung Biologics fell 3.5% and Celltrion was down 3.7%.Pharma stocks were broadly weaker in China too, with BeiGene down 6.2% and Jiangsu Hengrui Medicine off by 2.9%. In Hong Kong, WuXi Biologics shed 4.1% and Hansoh Pharmaceutical lost 2.95%.President Trump on Sunday said he would be instituting a policy known as \"Most Favo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"613df4b61bc3692be0fcc4204cdfad36","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","ONC","LU2148510915.USD","BK0239","LU0307460666.USD","BK1576","BK4007","LU0823426308.USD","LU0039217434.USD","BK1610","LU0051755006.USD","BK0188","LU0140636845.USD","SG9999002562.SGD","LU0348735423.USD","LU1720050803.USD","LU0572944931.SGD","LU0516423091.SGD","BK4526","LU0359202008.SGD","LU2488822045.USD","BK0183","LU0516422366.SGD","LU0405327148.USD","LU0405327494.USD","LU0516422440.USD","LU0359201612.USD","03692","03165","BK1583","SG9999002463.SGD","LU1328615791.USD","600276","02269","BK0060","DSNKY","LU0588546209.SGD","BK0196","LU0417516738.SGD","LU0320764599.SGD","BK1191","LU0456827905.SGD","LU1794554557.SGD","LU2039709279.SGD","RHHBY","IE00B0JY6N72.USD","LU1969619763.USD","LU0456846285.SGD","LU0181495838.USD","BK1141"],"gpt_icon":1},{"id":"2533459132","title":"BeiGene Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2533459132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533459132?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:47","pubTimestamp":1746715620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 10:47 ET (14:47 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","ONC"],"gpt_icon":0},{"id":"2533187470","title":"BeiGene price target raised to $350 from $348 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2533187470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533187470?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:39","pubTimestamp":1746707999,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Michael Schmidt raised the firm’s price target on BeiGene (ONC) to $350 from $348 and keeps a Buy rating on the shares. The firm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beigene-price-target-raised-to-350-from-348-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beigene-price-target-raised-to-350-from-348-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONC","BK4139"],"gpt_icon":0},{"id":"2533900520","title":"RBC Trims Price Target on BeiGene to $311 From $312, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2533900520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533900520?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:50","pubTimestamp":1746701418,"startTime":"0","endTime":"0","summary":"BeiGene's (ONC) US stock has an average rating of buy and mean price target of $334.87, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","06160"],"gpt_icon":0},{"id":"2533930030","title":"Beigene Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533930030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533930030?lang=en_us&edition=fundamental","pubTime":"2025-05-07 23:20","pubTimestamp":1746631242,"startTime":"0","endTime":"0","summary":"Beigene Ltd reports results for the quarter ended March 31 - Earnings SummaryBeigene Ltd ONC.OQ reported quarterly adjusted earnings of 1 cent per share for the quarter ended March 31, higher than the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF2JD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","688235"],"gpt_icon":0},{"id":"2533937422","title":"Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2533937422","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533937422?lang=en_us&edition=fundamental","pubTime":"2025-05-07 23:01","pubTimestamp":1746630086,"startTime":"0","endTime":"0","summary":"BeiGene posted a surprise Q1 profit and $1.12 billion in revenue, with strong U.S. Brukinsa sales, while reaffirming its 2025 outlook and margin guidance.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/05/45257204/chinese-biotech-beigene-stock-falls-despite-strong-brukinsa-sales-and-earnings-beat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","AMGN","06160"],"gpt_icon":0},{"id":"1171926967","title":"Stock Track | BeiGene Plunges 5.25% Pre-Market Despite Strong Q1 Results and Maintained 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1171926967","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171926967?lang=en_us&edition=fundamental","pubTime":"2025-05-07 20:49","pubTimestamp":1746622160,"startTime":"0","endTime":"0","summary":"BeiGene Ltd.  saw its stock price plummet 5.25% in pre-market trading on Wednesday, despite reporting strong first-quarter 2025 financial results and maintaining its full-year guidance. The global oncology company, which is set to change its name to BeOne Medicines Ltd., announced its Q1 performance and business updates after market close on Tuesday.Despite these positive results, investors seemed to focus on other aspects of the report. The company maintained its full-year 2025 revenue guidance","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | BeiGene Plunges 5.25% Pre-Market Despite Strong Q1 Results and Maintained 2025 Guidance","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"2533602172","title":"BeiGene Swings to Q1 Adjusted Earnings, Revenue Increases; 2025 Revenue Outlook Reiterated","url":"https://stock-news.laohu8.com/highlight/detail?id=2533602172","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533602172?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:24","pubTimestamp":1746613496,"startTime":"0","endTime":"0","summary":"BeiGene  reported Q1 adjusted earnings Wednesday of $1.22 per diluted American depositary share, swinging from an adjusted loss of $1.40 a year earlier.Comparable analyst estimates were not readily available.Revenue for the quarter ended March 31 was $1.12 billion, up from $751.7 million a year earlier.Analysts surveyed by FactSet expected $1.13 billion.For 2025, the biotech company continues to expect revenue of $4.9 billion to $5.3 billion.Analysts polled by FactSet expect $5.07 billion.Shares of the company were down more than 5% in recent premarket activity.Price: 229.00, Change: -12.75, Percent Change: -5.27","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06160","ONC"],"gpt_icon":0},{"id":"2533602667","title":"BeiGene sees FY25 revenue $4.9B-$5.3B, consensus $5.09B","url":"https://stock-news.laohu8.com/highlight/detail?id=2533602667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533602667?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:20","pubTimestamp":1746613237,"startTime":"0","endTime":"0","summary":"06:19 EDT BeiGene (ONC) sees FY25 revenue $4.9B-$5.3B, consensus $5.09B Published first on TheFly – the ultimate source for real-time, market-movin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beigene-sees-fy25-revenue-4-9b-5-3b-consensus-5-09b?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beigene-sees-fy25-revenue-4-9b-5-3b-consensus-5-09b?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONC"],"gpt_icon":0},{"id":"2533040586","title":"CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533040586","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533040586?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:11","pubTimestamp":1746612715,"startTime":"0","endTime":"0","summary":"CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45246969/correction-beigene-q1-adj-epads-1-22-beats-0-74-estimate-sales-1-12b-miss-1-14b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","06160"],"gpt_icon":0},{"id":"2533897085","title":"Beigene Ltd  expected to post a loss of 74 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533897085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533897085?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:43","pubTimestamp":1746448985,"startTime":"0","endTime":"0","summary":"Beigene Ltd  expected to post a loss of74cents a share - Earnings Preview Beigene Ltd ONC.OQ, ONC.O is expected to show a rise in quarterly revenue when it reports  results on May 7 for the period end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","ONC"],"gpt_icon":0},{"id":"2531078261","title":"3 Stocks That Could Be Trading Below Their Estimated Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2531078261","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531078261?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:37","pubTimestamp":1745926668,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 7.1%, contributing to a 7.7% increase over the past year, with earnings growth anticipated at 14% per annum in the coming years. In this environment, identifying stocks that may be trading below their estimated fair value can offer potential opportunities for investors looking to capitalize on future growth prospects.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Overview: Roku, Inc. operates a TV streaming platform both in the United States and internationally, with a market cap of approximately $9.59 billion.Roku's stock trades at US$68.14, significantly below its estimated fair value of US$135.48, highlighting potential undervaluation based on cash flows. Despite recent net losses, Roku's earnings are forecast to grow substantially over the next three years with expectations of profitability, surpassing average market growth rates. Recent product innovations and partnerships like Monste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-stocks-could-trading-below-113748231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","BK4211","FSRL","BK4227","BK4220","BK4548","LU2125909916.SGD","BK4585","BK4507","BK4106","BK4532","LU1878469433.USD","FOUR","BK4114","WIX","BK4524","IE0009354923.USD","LU0274383008.USD","LU1046422090.SGD","BK4505","BK4108","LU1861217088.USD","BK4139","BK4588","LU1861220207.SGD","LU1923622291.USD","LU2360107671.USD","MNSO","ROKU","ONC","LU1861558580.USD","LU2125909759.SGD"],"gpt_icon":0},{"id":"2530231257","title":"BeiGene Price Target Maintained With a $312.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2530231257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530231257?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:57","pubTimestamp":1745855820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2025 11:57 ET (15:57 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","06160"],"gpt_icon":0},{"id":"2529047945","title":"Exploring 3 High Growth Tech Stocks In The US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529047945","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529047945?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:38","pubTimestamp":1745408300,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 1.7% drop, but it has shown resilience with a 3.6% rise over the past year and an anticipated annual earnings growth of 13%. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability in alignment with these positive long-term market trends.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.Unlock comprehensive insights into our analysis of Bitdeer Technologies Group stock in this health report.Examine Bitdeer Technologies Group's past performance report to understand how it has performed in the past.Overview: Neurocrine Biosciences, Inc. focuses on discovering, developing, and marketing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders globally, with a market cap of approximately $10.04 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-high-growth-tech-113820363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","NBIX","ONC","BTDR","BK4595","BK4600"],"gpt_icon":0},{"id":"2529387869","title":"BeiGene Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2529387869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529387869?lang=en_us&edition=fundamental","pubTime":"2025-04-22 00:14","pubTimestamp":1745252040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 12:14 ET (16:14 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","ONC"],"gpt_icon":0},{"id":"2528791023","title":"BeiGene to Announce First Quarter 2025 Financial Results on May 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2528791023","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528791023?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:01","pubTimestamp":1744884060,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., April 17, 2025----BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., will report its first quarter 2025 financial results on Wednesday, May 7, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET.BeiGene, which plans to change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents. To learn more about BeiGene, please visit www.beigene.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beigene-announce-first-quarter-2025-100100561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ONC","BK4139"],"gpt_icon":0},{"id":"2526660207","title":"US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526660207","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526660207?lang=en_us&edition=fundamental","pubTime":"2025-04-11 22:03","pubTimestamp":1744380195,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration's plan to decrease preclinical animal study requirements for investigational new drug applications could be positive for the biotech sector as it may further encourage innovation, RBC Capital Markets said in a note emailed Friday.Antibody innovators like Regeneron Pharmaceuticals , Amgen , Viridian Therapeutics , BeiGene , Xencor , and Ultragenyx Pharmaceutical  stand to benefit the most from the new approach, the note said.RBC analysts said the move toward \"increased regulatory flexibility\" represents a \"net positive, especially given recent concerns about potential FDA dysfunction and potentially greater stringency.\"However, this \"will likely start small, and we are likely still years away from these specific approaches being proven and implemented on a broad enough scale to significantly affect the group,\" the note said.The regulatory move may be especially beneficial for \"early-stage development/new company creation, and reducing development time","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XNCR","LU2468319806.SGD","BK4599","LU2242652126.USD","LU0882574055.USD","REGN","BK4139","BK4566","ONC","LU0053666078.USD","LU1061106388.HKD","LU1571399168.USD","LU2362541273.HKD","LU2023250504.SGD","LU2362540622.SGD","LU0109394709.USD","LU0122379950.USD","LU1057294990.SGD","IE00B2B36J28.USD","VRDN","LU0114720955.EUR","LU1917777945.USD","LU2112291526.USD","RARE","LU0058720904.USD","LU0889565916.HKD","LU2362541513.USD","IE0002141913.USD","LU0320765992.SGD","BK4581","BK4585","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1974910355.USD","LU2089984988.USD","BK4534","IE00BFTCPJ56.SGD","LU2242646821.SGD","SG9999001440.SGD","AMGN","LU2106854487.HKD","LU0868494617.USD","LU2237438978.USD","BK4533","LU1983299246.USD","IE0009355771.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":97,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-Market","dateTimestamp":1756526400000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.6364,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":22,"updateTime":1748318400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-07-17","current":-84.275105,"percent":0.021127,"low":-89.808695,"twenty":-47.010053,"median":-39.274234,"eighty":-23.175318,"high":-19.234246,"avg":-40.083783,"sd":18.230961,"marketCap":33066685687},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-17","current":-84.275105,"twenty":-47.010053,"median":-39.274234,"eighty":-23.175318,"marketCap":33066685687}],"updateTime":1752830158615}}}